[1] Windpassinger C, Auer-Grumbach M, Irobi J, et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome[J]. Nat Genet, 2004, 36(3):271-276.
[2] Garg A. Acquired and inherited lipodystrophies[J]. N Engl J Med, 2004, 350(12):1220-1234.
[3] 张梦奇, 马明圣, 邱正庆. BSCL2基因突变致先天性全身脂肪营养不良症1例报告并文献复习[J]. 临床儿科杂志, 2017, 35(7):532-536.
[4] Jin J, Cao L, Zhao Z, et al. Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus[J]. Eur J Endocrinol, 2007, 157(6):783-787.
[5] Friguls B, Coroleu W, del Alcazar R, et al. Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation[J]. Eur J Med Genet, 2009, 52(1):14-16.
[6] 劳文芹, 孟哲, 欧辉, 等. 儿童Berardinelli-Seip综合征2例报告[J]. 中国实用儿科杂志, 2016, 31(2):157-158.
[7] 袁欣, 陈瑞敏, 王剑, 等. 先天性全身性脂肪营养不良BSCL2基因突变1例并文献复习[J]. 中国循证儿科杂志, 2016, 11(5):377-381.
[8] Huang HH, Chen TH, Hsiao HP, et al. A Taiwanese boy with congenital generalized lipodystrophy caused by homozygous Ile262fs mutation in the BSCL2 gene[J]. Kaohsiung J Med Sci, 2010, 26(11):615-620.
[9] Xueying Su, Ruizhu Lin, Yonglan Huang, et al. Clinical and mutational features of three Chinese children with congenital generalized lipodystrophy[J]. J Clin Res Pediatr Endocrinol, 2017, 9(1):52-57.
[10] Chen R, Yuan X, Wang J, et al. Clinical and molecular characterization of two Chinese patients with type 2 congenital generalized lipodystrophy[J]. Gene, 2017, 637:57-62.
[11] 陈瑞敏, 陈皓, 郭依华, 等. 全身性脂肪营养不良二例报道[J]. 中国优生与遗传杂志, 2002, 10(4):124.
[12] 蒋优君, 梁黎, 董关萍, 等. 先天性全身性脂肪营养不良一例[J]. 中华儿科杂志, 2004, 42(12):959.
[13] 赵诸慧, 沈水仙, 支涤静, 等. 儿童全身性脂肪营养不良伴糖尿病1例报告[J]. 临床儿科杂志, 2006, 24(12):1013-1014.
[14] Akinci G, Topaloglu H, Akinci B, et al. Spectrum of clinical manifestations in two young Turkish patients with congenital generalized lipodystrophy type 4[J]. Eur J Med Genet, 2016, 59(6-7):320-324.
[15] Schrauwen I, Szelinger S, Siniard AL, et al. A frame-shift mutation in CAV1 is associated with a severe neonatal progeroid and lipodystrophy syndrome[J]. PLoS One, 2015, 10(7):e0131797.
[16] Wu YR, Hung SI, Chang YC, et al. Complementary mutations in seipin gene in a patient with Berardinelli-Seip congenital lipodystrophy and dystonia:phenotype variability suggests multiple roles of seipin gene[J]. J Neurol Neurosurg Psychiatry, 2009, 80(10):1180-1181.
[17] Shirwalkar HU, Patel ZM, Magre J, et al. Congenital generalized lipodystrophy in an Indian patient with a novel mutation in BSCL2 gene[J]. J Inherit Metab Dis, 2008, 31(2):317-322.
[18] Ebihara K, Kusakabe T, Masuzaki H, et al. Gene and phenotype analysis of congenital generalized lipodystrophy in Japanese:a novel homozygous nonsense mutation in seipin gene[J]. J Clin Endocrinol Metab, 2004, 89(5):2360-2364.
[19] Nishiyama A, Yagi M, Awano H, et al. Two Japanese infants with congenital generalized lipodystrophy due to BSCL2 mutations[J]. Pediatr Int, 2010, 51(6):775-779.
[20] Rahman OU, Khawar N, Khan MA, et al. Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family[J]. Diagn Pathol, 2013, 8:78.
[21] Haghighi A, Kavehmanesh Z, Haghighi A, et al. Congenital generalized lipodystrophy:identification of novel variants and expansion of clinical spectrum[J]. Clin Genet, 2016, 89(4):434-441.
[22] Opri R, Fabrizi GM, Cantalupo G, et al. Progressive myoclonus epilepsy in congenital generalized lipodystrophy type 2:Report of 3 cases and literature review[J]. Seizure, 2016, 42:1-6.
[23] Purizaca-Rosillo N, Mori T, Benites-Cóndor Y, et al. High incidence of BSCL2 intragenic recombinational mutation in peruvian type 2 Berardinelli-Seip syndrome[J]. Am J Med Genet A, 2017, 173(2):471-478.
[24] Agarwal AK, Simha V, Oral EA, et al. Phenotypic and genetic heterogeneity in congeneralized lipodystrophy[J]. J Clin Endocrinol Metab, 2003, 88(10):4840-4847.
[25] Lundin C, Nordström R, Wagner K, et al. Membrane topology of the human seipin protein[J]. FEBS Lett, 2006, 580(9):2281-2284.
[26] Sim MF, Talukder MU, Dennis RJ, et al. Analyzing the functions and structure of the human lipodystrophy protein seipin[J]. Methods Enzymol, 2014, 537:161-175.
[27] Garg A, Misra A. Lipodystrophies:rare disorders causing metabolic syndrome[J]. Endocrinol Metab Clin North Am, 2004, 33(2):305-331.
[28] Diker-Cohen T, Cochran E, Gorden P, et al. Partial and generalized lipodystrophy:comparison of baseline characteristics and response to metreleptin[J]. J Clin Endocrinol Metab, 2015, 100(5):1802-1810.
[29] Patni N, Garg A. Congenital generalized lipodystrophies-new insights into metabolic dysfunction[J]. Nat Rev Endoerinol, 2015, 11(9):522-534.